您的位置: 首页 > 农业专利 > 详情页

Naphthyridine compounds as jak kinase inhibitors
专利权人:
LLC;Theravance Biopharma R&D IP
发明人:
HUDSON, Ryan,KOZAK, Jennifer,FATHEREE, Paul R.,PODESTO, Dante D.,BRANDT, Gary EL,FLEURY, Melissa,BEAUSOLEIL, Anne-Marie,HUANG, Xiaojun,THALLADI, Venkat R.
申请号:
AU2020202181
公开号:
AU2020202181A1
申请日:
2020.03.27
申请国别(地区):
AU
年份:
2020
代理人:
摘要:
#$%^&*AU2020202181A120200416.pdf#####1: Interwovn NRPortbl DCC AAR 20024698_I.docx-27/03/2020 ABSTRACT The invention provides compounds of formula (1): wherein the variables are defined in the specification, or a pharmaceutically-acceptable salt thereof, that are inhibitors of JAK kinases. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat inflammatory bowel diseases, and processes and intermediates useful for preparing such compounds.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充